OR WAIT null SECS
January 25, 2017
The company issues a voluntary nationwide recall due to the presence of particulate matter in a single vial.
January 09, 2017
The company was cited by FDA for violations of sterile processing GMPs.
December 02, 2016
Airlocks, gowning rooms, and transition spaces have different uses and should be considered separately in cGMP pharmaceutical facility design.
November 28, 2016
Wockhardt Limited received a warning letter from FDA for CGMP violations.
October 02, 2016
Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the assessment of risk in the processing of intravenous injectable drugs.
This key bioprocessing segment is expecting continued growth
September 23, 2016
Wells Pharmacy Network is voluntarily recalling all of its products due to sterility concerns.
September 14, 2016
FDA sent a warning letter to an Illinois compounding pharmacy for violations of the Federal Food, Drug, and Cosmetic Act.
September 02, 2016
A process-specific preventative maintenance program improves productivity and reliability.
Visual inspection of parenteral vials is the first step in a root cause investigation.